Received Oct 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 2 | 041B21A | IM / LA |
Chest pain and palpitations began the night after injections and were especially pronounced for several weeks but lingered until treatment. Fever and hot flashes, whole body tingling and burning sensations occurred the night following injection and intermittently until treatment, affecting sleep quality. Poor tolerance for alcohol and exercise, bloating and reflux, histamine intolerance, and chronic fatigue all developed over the following months and remain chronic. Cardiac MRI 13 December 2023 ruled out myocarditis. Additional chronic fatigue and brain fog, as well as intermittent jabbing pains in the extremities, led to getting treated for vaccine injury by clinic starting August 2024, which included 6 months of triple therapy (eliquis, plavix and aspirin) and mast cell stabilizers and antihistamines. This was supplemented with 40 hyperbaric chamber sessions. The treatment reduced most symptoms but did not eliminate them except for the chest pain and jabbing pain in extremities, bringing them to a chronic but manageable level.
None
None
None
None
Tested for amyloid fibrin microclots at Dr. office 22 Aug 2024, which came back grade 3/4 (moderate). Histamines 29 August 2024 came back high at 51 nmol/L which is over 6 times higher than the normal range of 0 to 8. Thrombin-antithrombin came back high at 4 mcg/L. Follow up testing for microclots came back 27 January 2025 as 2.5/4 or (mild), the goal for treatment.